-
Cannara Biotech Secures An Additional $10M In Non-Dilutive Capital With Its Lead Credit Provider, BMO Commercial Banking
Thursday, May 4, 2023 - 10:15am | 439Cannara Biotech Inc. (OTCQB: LOVFF) (TSXV:LOVE) (FRA:8CB) has raised an additional $10 million of credit facilities from its lead bank, BMO Commercial Banking via a $5 million increase in its term loan facility and a $5 million increase in its revolving line of credit. Under the terms of the...
-
Cannara Biotech Revenue Grows 41% YoY, Here Are The Details
Wednesday, July 27, 2022 - 9:06am | 671Cannara Biotech Inc. (OTCQB: LOVFF) (TSXV:LOVE) (FRA:8CB) fiscal Q3 2022 revenue was $10.1 million, a 36% increase from the previous quarter and a 41% increase compared to Q3 2021. Fiscal Q3 2022 Financial and Operational Highlights Recorded gross profit before fair value adjustments of $3.7...
-
Cannara Biotech Closes $50 Million Credit Facility Led By BMO Commercial Banking
Thursday, June 2, 2022 - 9:00am | 459Cannara Biotech Inc. (OTCQB: LOVFF) (TSXV:LOVE) (FRA:8CB) has closed on a $50M credit facility led by BMO Commercial Banking. The credit facility, effective May 31, 2022, includes a three-year term loan for $45 million with an accordion for up to an additional $10 million and a $5 million line of...